CFG
TMO icon

Clayton Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Clayton Financial Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-148
Closed -$72.7K – 515
2026
Q1 		$72.7K Hold
148
– – 0.04% 120
2025
Q4 		$85.8K Sell
148
-67
-31% -$37.9K 0.04% 116
2025
Q3 		$104K Buy
+215
New +$100K 0.08% 66
2024
Q4 		– Sell
-349
Closed -$216K – 126
2024
Q3 		$216K Sell
349
-4
-1% -$2.37K 0.08% 116
2024
Q2 		$205K Hold
353
– – 0.09% 100
2024
Q1 		$205K Buy
+353
New +$198K 0.09% 99

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Clayton Financial Group's TMO Position: Q2 2026 in Review

Clayton Financial Group sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 148 shares — an estimated $72.7K sold.

Clayton Financial Group first reported a position in TMO in Q1 2024 and held it in 6 quarters. The position peaked at $216K in Q3 2024. 568 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Clayton Financial Group reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Clayton Financial Group sold 148 Thermo Fisher Scientific shares in Q2 2026, an estimated $72.7K.
  • Clayton Financial Group first reported a position in Thermo Fisher Scientific in Q1 2024 and held it in 6 quarters.
  • Clayton Financial Group's Thermo Fisher Scientific position peaked at $216K in Q3 2024.
  • 568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.